News
09-26-2011, 02:11 AM
A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress [1]. Researchers think it could be the key for a greater understanding of the mechanisms of breast cancer recurrence as well as offering new options for patient care...
More... (http://www.medicalnewstoday.com/releases/234976.php)
More... (http://www.medicalnewstoday.com/releases/234976.php)